BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38381845)

  • 21. Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.
    García-Bernal D; Palomo M; Martínez CM; Millán-Rivero JE; García-Guillén AI; Blanquer M; Díaz-Ricart M; Sackstein R; Carreras E; Moraleda JM
    J Cell Mol Med; 2020 Jul; 24(14):8031-8044. PubMed ID: 32519822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.
    Holtan SG; Shabaneh A; Betts BC; Rashidi A; MacMillan ML; Ustun C; Amin K; Vaughn BP; Howard J; Khoruts A; Arora M; DeFor TE; Johnson D; Blazar BR; Weisdorf DJ; Wang J
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipocalin-2: a novel potential therapy for GVHD.
    Markey KA
    Trends Immunol; 2024 Apr; 45(4):231-233. PubMed ID: 38548552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft].
    Liu S; Zhou Z; Zhai WJ; Song XN; Li Q; Jiang EL; Feng SZ; Sun JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):539-545. PubMed ID: 37096531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
    Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
    Front Immunol; 2020; 11():593321. PubMed ID: 33584657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells.
    Griesenauer B; Jiang H; Yang J; Zhang J; Ramadan AM; Egbosiuba J; Campa K; Paczesny S
    J Immunol; 2019 May; 202(10):3053-3064. PubMed ID: 30979817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
    Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
    Front Immunol; 2018; 9():669. PubMed ID: 29740427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation.
    Delia M; Carluccio P; Mestice A; Chiusolo P; Metafuni E; Bellesi S; Arpinati M; Milone GA; Martino M; Mazza P; Ingrosso C; Vacca A; Saporiti G; Zallio F; Attolico I; Pastore D; Specchia G; Albano F; Musto P
    Transplant Cell Ther; 2021 Nov; 27(11):918.e1-918.e9. PubMed ID: 34403789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citrulline and Monocyte-Derived Macrophage Reactivity before Conditioning Predict Acute Graft-versus-Host Disease.
    Hueso T; Coiteux V; Joncquel Chevalier Curt M; Labreuche J; Jouault T; Yakoub-Agha I; Seguy D
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):913-921. PubMed ID: 28263922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
    Yu J; Parasuraman S; Shah A; Weisdorf D
    Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation between serum levels of IL-18 and acute graft versus host disease in patients after allogeneic hematopoietic stem cell transplantation].
    Liu J; Zhang XG; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):553-7. PubMed ID: 17605864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baicalin regulates autophagy to interfere with small intestinal acute graft-versus-host disease.
    Sun X; Pisano M; Xu L; Sun F; Xu J; Zheng W; Liu X; Zhang Y; Sun R; Cui X
    Sci Rep; 2022 Apr; 12(1):6551. PubMed ID: 35449393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
    Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
    Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Hermann A; Winkler A; Paschen C; Kuzmina Z; Hladik A; Icme S; Robak O
    Exp Hematol; 2019 Jun; 74():25-32.e1. PubMed ID: 31078634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation.
    Miyata M; Matsuki E; Ichikawa K; Takehara T; Hosokawa Y; Sekiguchi E; Peltier D; Reddy P; Ishizawa K; Watanabe M; Toubai T
    Blood Adv; 2023 Nov; 7(22):6936-6948. PubMed ID: 37748044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
    Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.